External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

UEG Week 2020

-
Coming soon
12:00 PM
Duration 7mins Virtual
GARDENIA: Etrolizumab versus infliximab for the treatment of ulcerative colitis
Silvio Danese

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
03:00 PM
Duration 7mins Virtual
HICKORY: Etrolizumab as Induction and Maintenance Therapy in Patients with Ulcerative Colitis Previously Exposed to Tumor Necrosis Factor Inhibitor
Laurent Peyrin-Biroulet

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 7mins Virtual
HIBISCUS I & II: Etrolizumab versus adalimumab versus placebo for the treatment of ulcerative colitis
Iris Dotan

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
03:00 PM
Duration 7mins Virtual
LAUREL: Etrolizumab as Maintenance Therapy in Tumor Necrosis Factor Inhibitor Naïve Patients with Ulcerative Colitis
Severine Vermeire

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar